MolGenie

MolGenie is utilizing and developing compound design technologies aimed at creating drug-like and selective small molecules with clear structure-activity relationships, good tolerability, and oral bioavailability. Founded in 2021, MolGenie aims to leverage its network of drug discovery and development experts to advance promising new therapeutic agents to IND application.